natgillin/translations-raw huggingface dataset:
Connect the syringe to the needle and inject into the base of the skin fold.
Namestite brizgo na iglo in vbrizgajte zdravilo v bazo kožne gube.
Improvements to the advice to physicians and access to appropriate medical information following poisoning are also likely to reduce the risk of severe effects as more effective hospital care might be available.
Tveganje hudih učinkov se bi verjetno zmanjšalo z izboljšanjem nasvetov za zdravnike in dostopa do ustreznih zdravstvenih podatkov po zastrupitvi, saj bi verjetno bila nudena bolj učinkovita bolnišnična oskrba.
Overall risk assessment
Skupna ocena tveganja
The CVMP did not consider it feasible or appropriate to recommend the re-formulation of the product to lower strength.
Po mnenju CVMP priporočilo o reformulaciji zdravila v šibkejšo obliko ni izvedljivo ali primerno.
Under paragraph 4.5 “Special precautions for use”
V odstavku 4.5 „Posebna opozorila in previdnostni ukrepi“
It must be noted that systems for properly recording suspected adverse reactions may not be in existence in every country in the world where the product is marketed.
Pri tem je treba upoštevati, da v vseh državah na svetu, kjer se zdravilo trži, niso vzpostavljeni sistemi beleženja sumov neželenih reakcij.
Doses of 2-3 ml have been reported to induce adverse effects.
Neželene učinke so povzročili odmerki 2-3 ml.
Single dose Sheep: 10 mg/kg bw
En odmerek Ovce: 10 mg/kg TM
Belgium Eli Lilly Benelux Stoofstraat 52
Eli Lilly Benelux Stoofstraat 52 1000 Brussels Belgija
A significant number of such users is likely to not fully understand the implications of the warnings and: o may not fully apply the measures intended to ensure their personal safety (i.e. the warning not to work alone is likely to be ignored; users may fail to detach the needle from the syringe containing the product and not fully understand the risks of accidental injection); o improperly store the product, potentially leading to easier availability for misuse and abuse; o may inappropriately use any product remaining following treatment of the original animal(s) at a later time point with consequential risks.
Številni uporabniki verjetno ne bodo popolnoma razumeli pomembnosti opozoril in: o ne bodo popolnoma upoštevali ukrepov, ki so namenjeni njihovi osebni varnosti (tj. opozorilo, da mora biti pri dajanju zdravila prisotnih več oseb, bo verjetno prezrto; uporabniki morda ne bodo sneli igle iz brizge z zdravilom in popolnoma razumeli tveganja nenamernega injiciranja); o bodo nepravilno hranili zdravilo, kar bo potencialno povzročilo lažjo dostopnost za nepravilno uporabo in zlorabo; o bodo lahko kasneje neprimerno porabili zdravilo preostalo po zdravljenju prvotne(ih) živali s posledičnimi tveganji.
Pneumonia: 10 mg/kg bw Interdigital necrobacillosis: 5 mg/kg bw subcutaneous use
Pljučnica: 10 mg/kg TM Interdigitalna nekrobaciloza: 5 mg/kg TM subkutana uporaba
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE IMMEDIATE (VIAL) LABEL - ALL AUTHORISED PACK SIZES
PODATKI NA STIČNI OVOJNINI NALEPKA NA STEKLENIČKI - VSE ODOBRENE VELIKOSTI PAKIRANJA
They are trained for and used to appropriate storage of potentially lethal products.
Usposobljeni so za shranjevanje potencialno smrtonosnih pripravkov in teh postopkov so tudi vajeni.
Tilmicosin is a macrolide antibiotic synthesized from tylosin which has an antibacterial spectrum similar to tylosin with enhanced activity against Pasteurella multocida and Pasteurella haemolytica.
Spekter bakterij, proti katerim je tilmikozin učinkovit, je podoben tilozinu, vendar ima povečano aktivnost proti bakterijama Pasteurella multocida in Pasteurella haemolytica.
Administration of intravenous calcium chloride should only be considered if there is positive confirmation of exposure to tilmicosin.
Uporabo intravenskega dajanja kalcijevega klorida preučite le po potrditvi izpostavitvi tilmikozinu.
In dog studies, tilmicosin induced a negative inotropic effect with consequent tachycardia, and a reduction in systemic arterial blood pressure and arterial pulse pressure.
Raziskave pri psih so pokazale, da tilmikozin sproži negativni inotropni učinek in naknadno tahikardijo ter znižanje sistemskega arterijskega krvnega tlaka ter arterijskega utripnega tlaka.
Cattle (calf)
Govedo (teleta)
Recommendation of harmonised, stringent EU user safety warnings including advice to the physician on appropriate treatment, and appropriate educational measures for users, without further restrictions
Priporočilo o usklajenih obveznih varnostnih opozorilih za uporabnike v EU, vključno z nasveti za zdravnike o ustreznem zdravljenju ter ustreznih izobraževalnih ukrepih za uporabnike brez dodatnih omejitev
Additional operator safety warnings:
Dodatna varnostna opozorila za osebo, ki daje zdravilo:
Recommendation of harmonised, stringent EU user safety warnings including advice to the physician on appropriate treatment, restriction of use to veterinary surgeons and other suitably qualified persons (as judged by the veterinary surgeons), and appropriate educational measures for users
Priporočilo o usklajenih obveznih varnostnih opozorilih za uporabnike v EU, vključno z nasveti za zdravnike o ustreznem zdravljenju, omejitvi uporabe na veterinarje in druge ustrezno usposobljene osebe (po presoji veterinarjev) ter ustreznih izobraževalnih ukrepih za uporabnike
or E. coli, two bacteria often the focus of human food-borne illness concerns.
Tilmikozin zlasti ni učinkovit proti vrstam iz rodu Salmonella in proti E. coli, dvema skupinama bakterij, ki pri človeku pogosto povzročajo bolezni preko živil.
Beta adrenergic antagonists such as propanolol exacerbated the negative inotrophy of tilmicosin in dogs.
Zaviralci betaadrenergičnih receptorjev, kot je propanolol, pri psih stopnjujejo negativno inotropijo tilmikozina.
CaCl2 treatment showed a positive inotropic effect on the left ventricular inotropic state after tilmicosin administration in beagle dogs.
Zdravljenje s CaCl2 je pokazalo pozitivni inotropni učinek na inotropno stanje levega prekata po dajanju tilmikozina psom pasme beagle.
Single dose 10 mg Tilmicosinum/ kg bw equivalent to 1 ml per 30 kg bw, during 3-4 days subcutaneous use.
En odmerek 10 mg Tilmicosinum/kg TM enakovredno 1 ml na 30 kg TM, v 3-4 dneh subkutana uporaba.
Dobutamine partially offset the negative inotrophic effects induced by tilmicosin in dogs.
Dobutamin pri psih delno kompenzira negativne inotropne učinke tilmikozina.
Recommendation of harmonised, stringent EU user safety warnings including advice to the physician on appropriate treatment, restriction of use to veterinary surgeons only, and appropriate educational measures for users
Priporočilo o usklajenih obveznih varnostnih opozorilih za uporabnike v EU, vključno z nasveti za zdravnike o ustreznem zdravljenju, omejitvi uporabe na samo veterinarje ter ustreznih izobraževalnih ukrepih za uporabnike
Non-lactating sheep
Ovce, ki niso v obdobju laktacije
Cattle, sheep and rabbit Single dose 10 mg tilmicosin/kg bw (1 ml/30 kg bw) subcutaneous use
Govedo, ovce in kunci En odmerek 10 mg tilmikozina/kg TM (1 ml/30 kg TM) subkutana uporaba
Intravenous injection of 4.5 to 5.6 mg tilmicosin/kg followed by intravenous injection of 1 ml epinephrine (1/1000) 2 to 6 times resulted in death of all 6 injected pigs.
Intravensko injiciranje od 4,5 do 5,6 mg tilmikozina/kg, kateremu je sledilo injiciranje 1 ml epinefrina (1/100) dva- do šestkrat, je povzročilo smrt pri vseh šestih prašičih, katerim so navedene pripravke injicirali.
Intraveneous injection of 4.5 and 5.6 mg tilmicosin/kg followed by intravenous injection of 1 ml epinephrine (1/1000) 2 to 6 times resulted in death of all 6 injected pigs.
Intravensko injiciranje 4,5 in 5,6 mg tilmikozina/kg, kateremu je sledilo injiciranje 1 ml epinefrina (1/100) dva- do šestkrat, je povzročilo smrt pri vseh šestih prašičih, katerim so navedene pripravke injicirali.
INJECTION OF THIS DRUG IN HUMANS CAN BE FATAL - EXERCISE EXTREME CAUTION TO AVOID ACCIDENTAL SELF-INJECTION AND FOLLOW THE ADMINISTRATION INSTRUCTIONS AND THE GUIDANCE BELOW, PRECISELY
INJICIRANJE TEGA ZDRAVILA LAHKO PRI ČLOVEKU POVZROČI SMRTBODITE ZELO PREVIDNI, DA PREPREČITE NENAMERNO SAMOINJICIRANJE.
In pigs, tilmicosin-induced lethality is potentiated by adrenalin.
Pri prašičih adrenalin poveča s tilmikozinom povzročeno smrtnost.
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE
ODMEREK ZA POSAMEZNE ŽIVALSKE VRSTE TER NAČIN UPORABE IN DAJANJA ZDRAVILA
• This product should only be administered by a veterinary surgeon.
• To zdravilo lahko daje samo veterinar.
In dogs, treatment with intravenous calcium chloride showed a positive effect on the left ventricular inotropic state and some improvements in vascular blood pressure and tachycardia.
Pri psih je intravensko dajanje kalcijevega klorida pokazalo pozitivni učinek na inotropno stanje levega prekata ter določeno izboljšanje žilnega krvnega tlaka in tahikardije.
Pigs given 4.5 to 5.6 mg tilmicosin/kg intravenously with no epinephrine all survived.
Vsi prašiči, katerim so intravensko dali od 4,5 do 5,6 mg tilmikozina/kg brez epinefrina, so preživeli.
Pigs given 4.5 and 5.6 mg tilmicosin/kg intravenously with no epinephrine all survived.
Vsi prašiči, katerim so intravensko dali 4,5 in 5,6 mg tilmikozina/kg brez epinefrina, so preživeli.
0.5 - 1ml Micotil per 30 kg bw (equivalent to 5-10mg tilmicosin per kg bw) subcutaneous use
0,5 - 1 ml zdravila Micotil na 30 kg TM, (enakovredno 5-10 mg tilmikozina na kg TM) subkutana uporaba
In one experiment isolated human cardiac atrial myocites were used to study the L-type Ca channel blocking profile.
V enem poskusu preučili profil blokiranja Ca-kanalčkov tipa L na izoliranih atrijskih miocitih iz človeškega srca.
Recommended dose Route of administration
Priporočeni odmerek Način uporabe zdravila
1ml Micotil per 30 kg bw (equivalent to 10mg tilmicosin per kg bw).
1 ml zdravila Micotil na 30 kg TM, (enakovredno 10 mg tilmikozina na kg TM).
METHOD AND ROUTE OF ADMINISTRATION
NAČIN UPORABE IN DAJANJA
Operator Safety Warnings:
Varnostna opozorila za osebo, ki daje zdravilo:
Single dose 1 ml/30 kg bw subcutaneous use
En odmerek 1 ml/30 kg TM subkutana uporaba
For animal treatment only to be supplied only on veterinary prescription.
Uporablja se le na osnovi recepta veterinarja.
• In case of human injection SEEK IMMEDIATE MEDICAL ATTENTION and take this vial or the package leaflet with you.
• V primeru injiciranja v človeka NEMUDOMA POIŠČITE ZDRAVNIŠKO POMOČ in s sabo vzemite to navodilo ali vialo.
However, the fact that the attending veterinary surgeon needs to ascertain the competence of the user, with both parties signing a form, is likely to minimise the risk of failure of this part of the measures; - While with this option the users of Micotil are more likely to understand the implications of the recommended warnings, a risk, though arguably lower than for option number 3, remains that: o the recommended measures intended to ensure their personal safety are not fully applied (i.e. the warning not to work alone is likely to be ignored; users may fail to detach the needle from the syringe containing the product and not fully understand the risks of accidental injection); o the product is not stored properly, potentially leading to easier availability for misuse and abuse; o any product remaining following treatment of the original animal(s) may be inappropriately used at a later time point with consequential risks.
Ker pa bo moral pristojni veterinar ugotoviti usposobljenost uporabnika, pri čemer bosta morali obe strani podpisati obrazec, je verjetno, da bo prišlo do zmanjšanja tveganja neuspeha tega dela ukrepov na najmanjšo raven; - Čeprav bodo v okviru te možnosti uporabniki zdravila Micotil bolj verjetno razumeli posledice priporočenih opozoril, še vedno obstaja tveganje, čeprav verjetno manjše od možnosti številka 3, da:
Single dose 10 mg tilmicosin per kg bw, corresponding to 1 ml Micotil 300 per 30 kg bw subcutaneous use
En odmerek 10 mg tilmikozina na kg TM, enakovredno 1 ml zdravila Micotil 300 na 30 kg TM
Single dose 1 ml Micotil 300 per 30 kg bw (10 mg tilmicosin/kg bw) subcutaneous use
En odmerek 1 ml zdravila Micotil 300 na 30 kg (10 mg tilmikozina/kg TM) subkutana uporaba
Single dose 10 mg tilmicosin per kg bw (1ml per 30 kg bw) subcutaneous use
En odmerek 10 mg tilmikozina na kg TM (1 ml na 30 kg TM) subkutana uporaba
In dogs, CaCl2 treatment showed a positive effect on the left ventricular inotrophic state after tilmicosin administration and some changes in vascular blood pressure and heart rate.
Pri psih je zdravljenje s CaCl2 po dajanju tilmikozina pokazalo pozitivni učinek na inotropno stanje levega prekata ter nekaj sprememb v žilnem krvnem tlaku in srčni frekvenci.
• In case of human injection SEEK IMMEDIATE MEDICAL ATTENTION and take the vial or the package leaflet with you.
• V primeru injiciranja v človeka NEMUDOMA POIŠČITE ZDRAVNIŠKO POMOČ in s sabo vzemite vialo ali navodilo.
Single dose 1 ml for 30 kg bw (i.e. 10 mg of tilmicosin/kg bw) subcutaneous use
En odmerek 1 ml na 30 kg TM (tj. 10 mg tilmikozina/kg TM) subkutana uporaba
The withdrawal of Micotil from the market in the EU has been considered in the risk analysis conducted by the CVMP and would reduce the risk of human fatalities or any human adverse reactions to zero.
V analizi tveganja je CVMP obravnaval umik zdravila Micotil iz prometa v EU.
- the Committee unanimously considered it necessary that the user safety warnings for the products concerned be harmonised throughout the EU in order to ensure appropriate user safety, in consideration of the referral question whether the wording with regard to the safety of users of the Micotil product literature should be harmonised;
- Odbor je po preučitvi vprašanja v napotitvi, ali naj se besedilo v zvezi z varnostjo uporabnikov v literaturi zdravila Micotil uskladi, soglasno ugotovil, da je nujno uskladiti varnostna opozorila za zadevno zdravilo po vsej EU, da se zagotovi ustrezno varnost uporabnikov.
Single dose 10 mg/kg bw subcutaneous use
En odmerek 10 mg/kg TM subkutana uporaba
Single dose 10 mg tilmicosin/kg bw subcutaneous use
En odmerek 10 mg tilmikozina/kg TM subkutana uporaba
This overview was last updated in February 2018.
Povzetek je bil nazadnje posodobljen februarja 2018.
Further information on Clevor can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Več informacij o zdravilu Clevor je na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
The European Medicines Agency decided that Clevor's benefits are greater than its risks and it can be authorised for use in the EU.
Evropska agencija za zdravila je odločila, da so koristi zdravila Clevor večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
Other information about Clevor
Druge informacije o zdravilu Clevor
Three dogs did not vomit at all despite a second dose.
Trije psi kljub drugemu odmerku niso bruhali.
If the dog does not vomit within 15 minutes of treatment, treatment may be repeated.
Če pes v 15 minutah po zdravljenju ne bruha, se mu lahko zdravilo da ponovno.
Clevor received a marketing authorisation valid throughout the EU on 13 April 2018.
Zdravilo Clevor je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji, 13/04/2018.
In a field trial involving 132 healthy dogs which compared Clevor with placebo (dummy treatment), 95% of the dogs vomited within 30 minutes.
V terenskem preskušanju, ki je vključevalo 132 zdravih psov, v njem pa so primerjali zdravilo Clevor s placebom (zdravilom brez zdravilne učinkovine), je 95 % psov bruhalo v 30 minutah.
Ropinirole is a dopamine agonist, which means that it imitates the action of dopamine.
Ropinirol je agonist dopamina, kar pomeni, da posnema delovanje dopamina.
People who are hypersensitive (allergic) to ropinirole should avoid contact with Clevor.
Ljudje, ki so preobčutljivi za (alergični na) ropinirol, se morajo izogibati stiku z zdravilom Clevor.
Pregnant or breast-feeding women should not handle this medicine.
Nosečnice in doječe matere ne smejo rokovati s tem zdravilom.
Clevor must not be used in dogs:
Zdravilo Clevor se ne sme uporabljati pri psih:
What are the risks associated with Clevor?
Kakšna tveganja so povezana z zdravilom Clevor?
Why is Clevor authorised in the EU?
Zakaj je zdravilo Clevor odobreno v EU?
An overview of Clevor and why it is authorised in the EU
Pregled zdravila Clevor in zakaj je odobreno v EU
It contains the active substance ropinirole.
Vsebuje zdravilno učinkovino ropinirol.
A second dose was given after 20 minutes to 13% of the dogs as they had not vomited.
Po 20 minutah so dali drugi odmerek 13 % psov, ki še niso bruhali.
The medicine should only be given by a veterinarian or under his/her close supervision and can only be obtained with a prescription.
Zdravilo lahko daje samo veterinar oziroma se lahko daje pod njegovim skrbnim nadzorom, predpisovanje in izdaja zdravila pa je le na recept.
In the group of 32 dogs which received placebo eye drops only one dog vomited.
V skupini 32 psov, ki so prejeli kapljice za oko s placebom, je bruhal samo en pes.
The most common side effects with Clevor (which may affect more than 1 in 10 animals) are shortlived, mild hyperaemia (redness) of the eye, discharge from the eye, protrusion of the third eyelid, blepharospasm (closure of the eyelids due to muscle contraction), short-lived mild lack of energy and increased heart rate.
Najpogostejši neželeni učinki zdravila Clevor (ki lahko prizadenejo več kot 1 žival od 10) so kratkotrajna, blaga hiperemija (pordelost) oči, izcedek iz oči, dvig tretje veke, blefarospazem (zapiranje vek zaradi mišičnih krčev), kratkotrajno blago pomanjkanje energije in pospešen srčni utrip.
What benefits of Clevor have been shown in studies?
Kakšne koristi je zdravilo Clevor izkazalo v študijah?
What is Clevor and what is it used for?
Kaj je zdravilo Clevor in za kaj se uporablja?
For more information about using Clevor, see the package leaflet or contact your veterinarian or pharmacist.
Za več informacij glede uporabe zdravila Clevor glejte navodilo za uporabo ali se posvetujte z veterinarjem ali farmacevtom.
Clevor is a veterinary medicine used to induce vomiting in dogs.
Clevor je zdravilo za uporabo v veterinarski medicini za sprožanje bruhanja pri psih.
• with central nervous system depression (low levels of consciousness), seizures (fits) or other problems with the nervous system which could lead to inhalation pneumonia (lung damage due to content from the stomach entering the lungs).
• z depresijo osrednjega živčevja (znižano ravnjo zavesti), epileptičnimi napadi (krči) ali drugimi težavami z živčevjem, ki bi lahko povzročile aspiracijsko pljučnico (poškodbo pljuč, ki je posledica vstopa želodčne vsebine v pljuča);
Clevor is an eye drop solution, given into the eye at a dose of 1-8 drops according to the dog's bodyweight.
Zdravilo Clevor je raztopina za kapljice za oko, ki se daje v oči v odmerku od ene do osmih kapljic, odvisno od telesne mase psa.
• which are hypoxic (have lower than normal oxygen levels in the blood), dyspnoeic (have difficulty breathing) or lack pharyngeal (swallowing) reflexes.
• ki so hipoksični (imajo znižano raven kisika v krvi), dispneični (imajo težave z dihanjem) ali nimajo faringealnih refleksov (refleksov požiranja);
For the full list of side effects and restrictions of Clevor, see the package leaflet.
Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Clevor glejte navodilo za uporabo.
By stimulating this part of the brain ropinirole triggers vomiting.
Ropinirol s stimuliranjem tega dela možganov sproži bruhanje.
If a dose of more than one drop is needed it should be divided between both eyes and when 6 or more drops are to be given the dose should be divided into 2 separate treatments given 12 minutes apart.
Kadar je treba dati šest kapljic ali več, je treba odmerek razdeliti v dve ločeni aplikaciji, ki jih damo eno do dve minuti narazen.
• which have swallowed sharp foreign objects, corrosive agents, volatile substances or organic solvents.
• ki so pogoltnili ostre tujke, korozivna sredstva, hlapne snovi ali organska topila.
Dopamine is a messenger substance in the part of the brain which controls vomiting.
Dopamin je prenašalec v tistem delu možganov, ki nadzira bruhanje.
If symptoms occur, medical advice should be sought and the package leaflet or label shown to the doctor.
Če se pojavijo neželeni učinki, nemudoma poiščite zdravniško pomoč in zdravniku pokažite navodilo za uporabo ali nalepko.
How is Clevor used?
Kako se zdravilo Clevor uporablja?
How does Clevor work?
Kako zdravilo Clevor deluje?
List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the member states
SEZNAM IMEN, FARMACEVTSKIH OBLIK, JAKOSTI ZDRAVILA, POTI UPORABE ZDRAVILA, PREDLAGATELJEV, IMETNIKOV DOVOLJENJA ZA PROMET Z ZDRAVILOM V DRŽAVAH ČLANICAH
Line Range Limited, c/o Orbis consumer products Limited,
Velika Britanija Line Range Limited, c/o Orbis consumer products Limited,
Bell Sons & Company Druggist limited.
Velika Britanija Bell Sons & Company Druggist limited.
Clarix sans sucre
Clarix sans sucre Sirup
Caltoson Balsamico Tablets
Caltoson Balsamico Tableta
Oral suspension Oral use
Peroralna suspenzija Peroralna uporaba
Diagonal, 67-69 Barcelona 08019 Spain pholcodine ; cineol ; cherry laurel water ; menthol ; terpineol ; benzocaine
Diagonal, 67-69 Barcelona 08019 Spain folkodin ; cineol ; voda lovorikovca mentol ; terpineol ; benzokain
Pinewood Laboratories Limited,
Velika Britanija Pinewood Laboratories Limited,
Luxembourg COOPERATION PHARM.FRANCAISE PLACE LUCIEN AUVERT 77020 MELUN CEDEX France
Luksemburg COOPERATION PHARM.FRANCAISE PLACE LUCIEN AUVERT 77020 MELUN CEDEX France
Beecham Group PLC, 980 Great West Road, Brentford,
Velika Britanija Beecham Group PLC, 980 Great West Road, Brentford,
Belgium pholcodine thiophene carboxylate eucalyptus huile essentielle parahydroxybenzoate de methyle parahydroxybenzoate de propyle
Belgium folkodin tiofenijev karboksilat esencialno olje evkaliptola metilparahidroksib enzoat parahydroxybenzo ate de propyle
Day Nurse Capsules Capsule, hard Oral use
Day Nurse Capsules Kapsula, trda
Wise Pharmaceuticals Limited,
Velika Britanija Wise Pharmaceuticals Limited,
Sterling Pharmaceuticals Limited,
Velika Britanija Sterling Pharmaceuticals Limited,
Alliance Pharmaceuticals Limited,
Velika Britanija Alliance Pharmaceuticals Limited,
Belgium Sanofi-Aventis Belgium NV Culliganlaan 1C
Sanofi-Aventis Belgium NV
Ayrton Saunders Limited, North Way,
Velika Britanija Ayrton Saunders Limited,
myrte (huile essentielle de) (deterpenee) ; alpha-terpinéol ; pholcodine
mirta (esencialno olje), alfaterpineol ; folkodin
Promethazine Hydrochloride, Paracetamol, Dextromethorphan hydrobromide Pholcodine;
Promethazine Hydrochloride, Paracetamol, Dekstrometorfanij ev hidrobromid Folkodin;
Thornton & Ross Limited, Linthwaite,
Velika Britanija Thornton & Ross Limited,
Cotrane Pholcodine Syrup
Cotrane Pholcodine Sirup
Pholco-mereprine
Pholco-mereprine Sirup
Belgium doxylamine pholcodine benzoate sodique sulfogaiacol
Belgium doksilamin folkodin benzojska kislina sulfogaiakol
Pholcodyl, sirop
Pholcodyl, sirop Sirup
Ephedromel, sirop Syrup
Ephedromel, sirop Sirup
biclotymol ; cinéole ; pholcodine
biklotimol ; cineol; folkodin
Belgium pholcodine 15 mg/15ml Sulfogaiacol 300 mg/15ml
8560 Wevelgem Belgium folkodin 15 mg/15ml Sulfogaiakol 300 mg/15ml
Cotrane Folcodine
Cotrane Folcodine Sirup
Day time cold relief
Day time cold relief Peroralna tekočina Peroralna uporaba
Psedoephedrine Hydrochloride ;
Psevdoefedrin Hydrochloride ;
Biocalyptol, sirop
Biocalyptol, sirop Sirup
Pholcodine, Chlorphenamine, Biclotymolm
Folkodin, Klorfenamin, Biklotimolm
Belgium pholcodine eucalyptolum camphora syntheticum gaiacolum phenolum
8560 Wevelgem Belgium folkodin evkaliptolum camphora syntheticum gaiacolum fenol
Pholco Mereprine
Pholco Mereprine Sirup
Belgium camphre eucalyptol gaiacol phenol pholcodine
Belgium kafra evkaliptol gaiacol fenol folkodin
pholcodine ; érysimum (extrait sec d')
folkodin ; šebenik (suhi ekstrakt)
Pholcodine, Chlorphenamine, Biclotymol
Folkodin, Klorfenamin, Biklotimol